RIFAMPIN - Generic Drug Details

✉ Email this page to a colleague

What are the generic drug sources for rifampin and what is the scope of freedom to operate?

Rifampin is the generic ingredient in three branded drugs marketed by Sanofi Aventis Us, Chartwell Molecular, Epic Pharma Llc, Hikma, Lupin Pharms, Oxford Pharms, Avet Lifesciences, Fresenius Kabi Usa, Hikma Pharms, Mylan Labs Ltd, and Watson Pharms Teva, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are nine drug master file entries for rifampin. Fourteen suppliers are listed for this compound.

Sponsor	Phase
Guangdong Raynovent Biotech Co., Ltd	Phase 1
Ministry of Health, France	Phase 3
Assistance Publique Hopitaux De Marseille	Phase 3

Sponsor

Phase

Guangdong Raynovent Biotech Co., Ltd

Phase 1

Ministry of Health, France

Phase 3

Assistance Publique Hopitaux De Marseille

Phase 3

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Oxford Pharms	RIMACTANE	rifampin	CAPSULE;ORAL	050429-001	Approved Prior to Jan 1, 1982	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Hikma Pharms	RIFAMPIN	rifampin	INJECTABLE;INJECTION	205039-001	Mar 3, 2016	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Mylan Labs Ltd	RIFAMPIN	rifampin	INJECTABLE;INJECTION	065421-001	May 22, 2008	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Chartwell Molecular	RIFAMPIN	rifampin	CAPSULE;ORAL	065390-002	Mar 28, 2008	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Hikma	RIFAMPIN	rifampin	INJECTABLE;INJECTION	064217-001	Oct 29, 1999	AP	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Avet Lifesciences	RIFAMPIN	rifampin	INJECTABLE;INJECTION	204101-001	Aug 18, 2014		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Lupin Pharms	RIFAMPIN	rifampin	CAPSULE;ORAL	090034-001	Aug 21, 2013	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

US Patents:	0
Tradenames:	3
Applicants:	11
NDAs:	15
Drug Master File Entries:	9
Finished Product Suppliers / Packagers:	14
Raw Ingredient (Bulk) Api Vendors:	47
Clinical Trials:	307
Patent Applications:	7,270
Drug Prices:	Drug price trends for RIFAMPIN
What excipients (inactive ingredients) are in RIFAMPIN?	RIFAMPIN excipients list
DailyMed Link:	RIFAMPIN at DailyMed